Disulfide bridge disruption in the alpha2 domain of the HLA class I molecule leads to low expression of the corresponding antigen
- PMID: 16916654
- DOI: 10.1016/j.humimm.2006.04.010
Disulfide bridge disruption in the alpha2 domain of the HLA class I molecule leads to low expression of the corresponding antigen
Abstract
Using sequence-based typing, we have identified a novel human leukocyte antigen (HLA)-A*30 allele, HLA-A*3014L, with a low expression pattern. The sequence of HLA-A*3014L is identical to that of HLA-A*3001 except for a G to C substitution in exon 3 at nucleotide position 563, resulting in an amino acid difference at position 164 (Cys to Ser). Due to the cysteine substitution, a disulfide bridge in the alpha2 domain of the HLA class I heavy chain cannot be formed. By using the standard microlymphocytotoxicity test, the HLA-A30 antigen cannot be detected. By flow cytometric analysis of the cell-surface expression at either 37 degrees C or 30 degrees C, a temperature-sensitive expression pattern of the HLA-A*3014L antigen was observed. Only by incubating the cells at 30 degrees C, which increases the stability of HLA class I heavy chains, was a weak but clearly detectable HLA-A*3014L expression found. The mRNA expression level of the HLA-A*3014L allele was not affected by the nucleotide substitution. The intrachain disulfide bond formation in the alpha2 domain is essential for the normal expression of the HLA molecules. Reduced protein expression is probably caused by incorrect HLA class I heavy chain folding and HLA class I complex assembly.
Similar articles
-
The nature of peptides presented by an HLA class I low expression allele.Haematologica. 2010 Aug;95(8):1373-80. doi: 10.3324/haematol.2009.016089. Epub 2010 Mar 10. Haematologica. 2010. PMID: 20220067 Free PMC article.
-
Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA.Mol Immunol. 2009 Apr;46(7):1451-7. doi: 10.1016/j.molimm.2008.12.011. Epub 2009 Feb 4. Mol Immunol. 2009. PMID: 19195705
-
Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line.J Immunol. 1994 Dec 15;153(12):5525-36. J Immunol. 1994. PMID: 7989754
-
Structural studies on HLA-G: implications for ligand and receptor binding.Hum Immunol. 2007 Apr;68(4):220-6. doi: 10.1016/j.humimm.2006.09.003. Epub 2006 Oct 27. Hum Immunol. 2007. PMID: 17400055 Review.
-
Structure, expression and function of HLA-G in renal cell carcinoma.Semin Cancer Biol. 2007 Dec;17(6):444-50. doi: 10.1016/j.semcancer.2007.07.001. Epub 2007 Jul 13. Semin Cancer Biol. 2007. PMID: 17707652 Review.
Cited by
-
Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.Sci Rep. 2019 May 30;9(1):8067. doi: 10.1038/s41598-019-44336-7. Sci Rep. 2019. PMID: 31147565 Free PMC article.
-
The nature of peptides presented by an HLA class I low expression allele.Haematologica. 2010 Aug;95(8):1373-80. doi: 10.3324/haematol.2009.016089. Epub 2010 Mar 10. Haematologica. 2010. PMID: 20220067 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials